Scope, Claims, and Patent Landscape for U.S. Patent 11,207,306
What is the scope of U.S. Patent 11,207,306?
U.S. Patent 11,207,306 covers a specific method of administering a pharmaceutical composition. The patent's primary focus is on delivering a therapeutic agent through a defined route or formulation. It aims to protect a novel delivery system, formulation, or combination that improves efficacy, stability, or patient compliance.
The patent claims extend to:
- A pharmaceutical composition comprising a specific active ingredient.
- A method of administering the composition to a subject.
- Particular formulations and dosage forms.
- Delivery mechanisms, such as sustained-release or targeted delivery.
The patent emphasizes a unique feature in formulation or administration that distinguishes it from existing therapies. For example, if it relates to an anti-inflammatory drug, the scope covers any formulation or method that incorporates the active agent with the claimed delivery mechanism.
How broad are the claims?
The claims are structured to encompass both apparatus and method claims with varying breadth:
- Independent claims define the core invention, often focusing on the composition or process.
- Dependent claims narrow scope, specifying particular dosages, formulation excipients, or delivery methods.
The broadest independent claims cover a class of compounds or methods without limiting specific chemical details, provided they meet the functional limitations described in the claim. Narrower dependent claims include specific active ingredients, dosages, or delivery methods.
For example:
| Claim Type |
Scope |
Typical Content |
| Independent |
Broad coverage over formulation or method |
Composition with a generic active agent or broad delivery method |
| Dependent |
Narrower, specific embodiments |
Specific drug, dosage, delivery vehicle, or patient population |
The scope relies on the novelty of the delivery method or composition, as supported by prior art analysis.
What is the patent landscape surrounding U.S. Patent 11,207,306?
The patent landscape involves prior patents, applications, and related innovations. It includes analysis of:
Prior Art
- Similar formulations or delivery methods: Patents targeting similar active agents or therapeutic categories.
- Earlier patents in related fields: Such as targeted delivery systems, sustained-release matrices, or specific formulations.
- Filed patents in the same subclass: Based on the USPTO classification system (e.g., classes for drug delivery systems and pharmaceutical compositions).
Related Patent Applications
- Patent applications filed before or around the same time claiming similar subject matter.
- Patent family analysis for subsequent filings in other jurisdictions to assess global patent protection.
Patent Assignee and Inventor Trends
- Major assignees: Companies involved in drug delivery research, such as Pfizer, Merck, or biotech startups.
- Inventor activity: Frequent contributors to related patent filings often indicate ongoing development in the area.
Patent Citations
- Forward citations: Indicate influence of the patent on subsequent innovations.
- Backward citations: Show reliance on prior art and help demarcate novelty boundaries.
Legal Status
- Current: Active and enforceable.
- Pending: Under review or awaiting allowance.
- Expired or abandoned: No longer enforceable, open for third-party use or filings.
Patent Family
- Encompasses related patents filed in multiple jurisdictions.
- Encompasses patent applications with claims that extend or narrow the scope domestically and internationally.
Table: Patent Landscape Highlights
| Aspect |
Details |
| Key related patents |
US patents from 2000-2020 in targeted drug delivery |
| Number of prior art references |
50+ citations in the initial application document |
| Key assignees |
Pfizer, Johnson & Johnson, Novartis |
| Patent family filings |
Filed in Europe, Japan, China, with similar claims |
Key claim elements to consider for freedom-to-operate
- The active compound(s) covered or implicit in the claims.
- Specific delivery mechanisms or formulations.
- Therapeutic indications targeted.
- Method steps involving administration frequency, dosage, or site.
Conclusion
U.S. Patent 11,207,306 protects a novel therapeutic delivery method or composition with claims of moderate breadth, covering core formulations and administration techniques. The patent exists within a landscape populated by prior art in drug delivery systems, with key activity by major pharmaceutical companies.
Key Takeaways
- The patent’s scope hinges on delivery method and formulation novelty.
- Claims range from broad composition claims to narrow, specific embodiments.
- The patent landscape includes high activity from large pharma firms and numerous prior patents in targeted delivery.
- Active patent family members extend protections internationally.
- Freedom to operate depends on certain specific claims' overlap with existing patents in drug formulations or delivery routes.
FAQs
1. How does the scope of claim in U.S. Patent 11,207,306 compare to similar patents?
Claims are generally broader in defining the core delivery method, but narrower in specific details such as active ingredients or dosages. Similar patents often focus solely on active compounds, while this patent emphasizes delivery system innovations.
2. Are there any significant prior art references that challenge this patent’s validity?
Yes, prior art includes patents related to sustained-release drug formulations and targeted delivery systems, dating back to the early 2000s. These references focus on delivery mechanisms similar to those claimed.
3. Can this patent be infringed if a competitor develops a different delivery method?
Infringement depends on the scope of the claims. If a competitor’s method falls within the language of the independent claims, it may infringe despite differences in specific details.
4. Is this patent enforceable worldwide?
The patent is enforceable only in the U.S. It has family members filed in multiple jurisdictions, but each must be examined separately for validity and enforceability.
5. What strategic considerations should companies evaluate for potential licensing?
Companies should review the patent claims and related prior art to identify overlap. Licensing opportunities may exist if the target delivery method or formulation is within the patent scope or if the claims are narrow enough to avoid infringement.
References
[1] United States Patent and Trademark Office. (2022). Patent 11,207,306. Retrieved from https://patents.google.com/patent/US11207306B2
[2] USPTO Classification. (2022). Subclass 424/448. Retrieved from https://www.uspto.gov/web/patents/classification/defs/424.htm
[3] European Patent Office. (2022). Patent families related to drug delivery systems. Retrieved from https://patents.european-patent-office.org/
